Company profile
Deciduous Therapeutics
Deciduous is developing a novel class of immune-modulatory therapies designed to promote a healthy lifespan.
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- San Francisco, California
- LinkedIn followers
- 4,402
- Office locations
- 1
Deciduous Therapeutics company summary
Deciduous Therapeutics is a company in the Biotechnology Research industry, headquartered in San Francisco, California. On LinkedIn the company has around 12 employees and 4,402 followers.
What technology does Deciduous Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Deciduous Therapeutics
Senescent cells, which are characterized by irreversible damage and an inflammatory secretome, are considered a key driving force behind many age-related diseases. Due to a failure in immune surveillance, senescent cells accumulate and impact their local environment by inducing inflammation and promoting extracellular matrix remodeling, thus resulting in a myriad of metabolic and fibrotic consequences. Therefore, enabling the removal of senescent cells dramatically ameliorates disease pathologies in many age-related diseases, leading to overall improvements in health-span. At Deciduous Therapeutics, we have discovered novel molecules that can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells and thereby treat several classes of age-related diseases.
Where is Deciduous Therapeutics located?
Deciduous Therapeutics lists 1 location.
Compare companies similar to Deciduous Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Deciduous Therapeutics deciduoustx.com | Biotechnology Research | 12 | - | San Francisco, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Deciduous Therapeutics
What does Deciduous Therapeutics do?
Senescent cells, which are characterized by irreversible damage and an inflammatory secretome, are considered a key driving force behind many age-related diseases. Due to a failure in immune surveillance, senescent cells accumulate and impact their local environment by inducing inflammation and promoting extracellular matrix remodeling, thus resulting in a myriad of metabolic and fibrotic consequences. Therefore, enabling the removal of senescent cells dramatically ameliorates disease pathologies in many age-related diseases, leading to overall improvements in health-span. At Deciduous Therapeutics, we have discovered novel molecules that can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells and thereby treat several classes of age-related diseases.
How many employees does Deciduous Therapeutics have?
Deciduous Therapeutics has around 12 employees on LinkedIn.
Where is Deciduous Therapeutics headquartered?
Deciduous Therapeutics is headquartered in San Francisco, California.
Build a lead list from companies like Deciduous Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.